Tobacco and other environmental risk factors in rheumatoid arthritis;Tabaco y otros factores ambientales en la artritis reumatoide

Reumatologia Clinica

Volumn 8, Issue 6, 2012, Pages 342-350

  Ruiz Esquide, Virginia ^a   Sanmartí, Raimon ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Environmental risk factors; Rheumatoid arthritis; Tobacco

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ENVIRONMENTAL FACTOR; HUMAN; PHENOTYPE; RHEUMATOID ARTHRITIS; RISK FACTOR; SHORT SURVEY; SMOKING; TOBACCO; TREATMENT RESPONSE;

ARTHRITIS, RHEUMATOID; DIET; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; INFECTION; RISK FACTORS; SILICON DIOXIDE; SMOKING; SOCIOECONOMIC FACTORS;

EID: 84868610207     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2012.02.011     Document Type: Short Survey

References (123)

1. Heliovaara M., Aho K., Aromaa A., Knekt P., Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol 1993, 20:1830-1835.
2. Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976, 57:1148-1157.
3. MacGregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., Aho K., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000, 43:30-37.
4. Seldin M.F., Amos C.I., Ward R., Gregersen P.K. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999, 42:1071-1079.
5. John S., Myerscough A., Marlow A., Hajeer A., Silman A., Ollier W., et al. Linkage of cytokine genes to rheumatoid arthritis Evidence of genetic heterogeneity. Ann Rheum Dis 1998, 57:361-365.
6. Mattey D.L., Hutchinson D. Smoking and HLA-DR shared epitope alleles in rheumatoid arthritis: comment on the article by Padyukov et al. Arthritis Rheum 2005, 52:3676-3678. 3675-6; author reply.
7. Karlson E.W., Chang S.C., Cui J., Chibnik L.B., Fraser P.A., De Vivo I., et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010, 69:54-60.
8. Kallberg H., Padyukov L., Plenge R.M., Ronnelid J., Gregersen P.K., Van der Helm-Van Mil AH, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007, 80:867-875.
9. Oliveira R.D., Junta C.M., Oliveira F.R., Silva L.M., Donadi E.A., Louzada-Junior P. Share epitope, citrullinated cyclic peptide antibodies and smoking in Brazilian rheumatoid arthritis patients. Clin Rev Allergy Immunol 2008, 34:32-35.
10. Padyukov L., Silva C., Stolt P., Alfredsson L., Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004, 50:3085-3092.
11. Sanmarti R., Gomez-Centeno A., Ercilla G., Larrosa M., Vinas O., Vazquez I., et al. Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids. Clin Rheumatol 2007, 26:1111-1118.
12. Hall F.C., Weeks D.E., Camilleri J.P., Williams L.A., Amos N., Darke C., et al. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. Qjm 1996, 89:821-829.
13. Turesson C., Schaid D.J., Weyand C.M., Jacobsson L.T., Goronzy J.J., Petersson I.F., et al. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 2005, 7:R1386-R1393.
14. Cornelis F., Faure S., Martinez M., Prud'homme J.F., Fritz P., Dib C., et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 1998, 95:10746-10750.
15. Jawaheer D., Gregersen P.K. Rheumatoid arthritis The genetic components. Rheum Dis Clin North Am 2002, 28. 1-15, v.
16. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330-337.
17. Lee A.T., Li W., Liew A., Bombardier C., Weisman M., Massarotti E.M., et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 2005, 6:129-133.
18. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
19. Orozco G., Alizadeh B.Z., Delgado-Vega A.M., Gonzalez-Gay M.A., Balsa A., Pascual-Salcedo D., et al. Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. Arthritis Rheum 2008, 58:1974-1980.
20. Plenge R.M. Recent progress in rheumatoid arthritis genetics: one step towards improved patient care. Curr Opin Rheumatol 2009, 21:262-271.
21. Kurreeman F.A., Padyukov L., Marques R.B., Schrodi S.J., Seddighzadeh M., Stoeken-Rijsbergen G., et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007, 4:e278.
22. Nelson J.L., Hughes K.A., Smith A.G., Nisperos B.B., Branchaud A.M., Hansen J.A. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993, 329:466-471.
23. Jorgensen C., Picot M.C., Bologna C., Sany J. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 1996, 55:94-98.
24. Berglin E., Kokkonen H., Einarsdottir E., Agren A., Rantapaa Dahlqvist S. Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study. Scand J Rheumatol 2010, 39:454-460.
25. Doran M.F., Crowson C.S., O'Fallon W.M., Gabriel S.E. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 2004, 31:207-213.
26. Brennan P., Bankhead C., Silman A., Symmons D. Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study. Semin Arthritis Rheum 1997, 26:817-823.
27. Pedersen M., Jacobsen S., Klarlund M., Pedersen B.V., Wiik A., Wohlfahrt J., et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 2006, 8:R133.
28. Karlson E.W., Mandl L.A., Hankinson S.E., Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004, 50:3458-3467.
29. Pikwer M., Bergstrom U., Nilsson J.A., Jacobsson L., Berglund G., Turesson C. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009, 68:526-530.
30. Vessey M.P., Villard-Mackintosh L., Yeates D. Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception 1987, 35:457-464.
31. Pladevall-Vila M., Delclos G.L., Varas C., Guyer H., Brugues-Tarradellas J., Anglada-Arisa A. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol 1996, 144:1-14.
32. Pikwer M., Bergstrom U., Nilsson J.A., Jacobsson L., Turesson C. Early menopause is an independent predictor of rheumatoid arthritis. Ann Rheum Dis 2011.
33. Heikkila R., Aho K., Heliovaara M., Knekt P., Reunanen A., Aromaa A., et al. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis 1998, 57:281-285.
34. Bengtsson C., Nordmark B., Klareskog L., Lundberg I., Alfredsson L. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005, 64:1588-1594.
35. Pedersen M., Jacobsen S., Klarlund M., Frisch M. Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study. J Rheumatol 2006, 33:1069-1074.
36. Bergstrom U., Jacobsson L.T., Nilsson J.A., Berglund G., Turesson C. Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis. Rheumatology (Oxford) 2011, 50:2005-2013.
37. Rosell M., Wesley A.M., Rydin K., Klareskog L., Alfredsson L. Dietary fish and fish oil and the risk of rheumatoid arthritis. Epidemiology 2009, 20:896-901.
38. Pattison D.J., Harrison R.A., Symmons D.P. The role of diet in susceptibility to rheumatoid arthritis: a systematic review. J Rheumatol 2004, 31:1310-1319.
39. Benito-Garcia E., Feskanich D., Hu F.B., Mandl L.A., Karlson E.W. Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther 2007, 9:R16.
40. Nielen M.M., Van Schaardenburg D., Lems W.F., Van de Stadt R.J., De Koning M.H., Reesink H.W., et al. Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al. Arthritis Rheum 2006, 54:3719-3720.
41. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
42. Merlino L.A., Curtis J., Mikuls T.R., Cerhan J.R., Criswell L.A., Saag K.G. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004, 50:72-77.
43. Patel S., Farragher T., Berry J., Bunn D., Silman A., Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007, 56:2143-2149.
44. Haque U.J., Bartlett S.J. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 2010, 28:745-747.
45. Kerr G.S., Sabahi I., Richards J.S., Caplan L., Cannon G.W., Reimold A., et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 2011, 38:53-59.
46. Kallberg H., Jacobsen S., Bengtsson C., Pedersen M., Padyukov L., Garred P., et al. Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies. Ann Rheum Dis 2009, 68:222-227.
47. Karlson E.W., Mandl L.A., Aweh G.N., Grodstein F. Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum 2003, 48:3055-3060.
48. Mikuls T.R., Cerhan J.R., Criswell L.A., Merlino L., Mudano A.S., Burma M., et al. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2002, 46:83-91.
49. Heliovaara M., Aho K., Knekt P., Impivaara O., Reunanen A., Aromaa A. Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis 2000, 59:631-635.
50. de Pablo P., Dietrich T., McAlindon T.E. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008, 35:70-76.
51. Lundberg K., Wegner N., Yucel-Lindberg T., Venables P.J. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol 2010, 6:727-730.
52. Rosenstein E.D., Greenwald R.A., Kushner L.J., Weissmann G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 2004, 28:311-318.
53. Marotte H., Farge P., Gaudin P., Alexandre C., Mougin B., Miossec P. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis 2006, 65:905-909.
54. Stolt P., Yahya A., Bengtsson C., Kallberg H., Ronnelid J., Lundberg I., et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann Rheum Dis 2010, 69:1072-1076.
55. Hazes J.M., Dijkmans B.A., Vandenbroucke J.P., de Vries R.R., Cats A. Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis 1990, 49:980-982.
56. Hernandez Avila M., Liang M.H., Willett W.C., Stampfer M.J., Colditz G.A., Rosner B., et al. Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology 1990, 1:285-291.
57. Symmons D.P., Bankhead C.R., Harrison B.J., Brennan P., Barrett E.M., Scott D.G., et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997, 40:1955-1961.
58. Karlson E.W., Lee I.M., Cook N.R., Manson J.E., Buring J.E., Hennekens C.H. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 1999, 42:910-917.
59. Sopori M.L., Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol 1998, 83(1-2):148-156.
60. Arnson Y., Shoenfeld Y., Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010, 34:J258-J265.
61. Majo J., Ghezzo H., Cosio M.G. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001, 17:946-953.
62. Pryor W.A., Stone K., Zang L.Y., Bermudez E. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol 1998, 11:441-448.
63. Formica M.K., Palmer J.R., Rosenberg L., McAlindon T.E. Smoking, alcohol consumption, and risk of systemic lupus erythematosus in the Black Women's Health Study. J Rheumatol 2003, 30:1222-1226.
64. Bengtsson A.A., Rylander L., Hagmar L., Nived O., Sturfelt G. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 2002, 41:563-571.
65. Hernan M.A., Olek M.J., Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001, 154:69-74.
66. Riise T., Nortvedt M.W., Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 2003, 61:1122-1124.
67. Holm I.A., Manson J.E., Michels K.B., Alexander E.K., Willett W.C., Utiger R.D. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Arch Intern Med 2005, 165:1606-1611.
68. Vestergaard P., Rejnmark L., Weeke J., Hoeck H.C., Nielsen H.K., Rungby J., et al. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 2002, 12:69-75.
69. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005, 42:1194-1202.
70. Hutchinson D., Shepstone L., Moots R., Lear J.T., Lynch M.P. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 2001, 60:223-227.
71. Krishnan E. Smoking, gender and rheumatoid arthritis-epidemiological clues to etiology Results from the behavioral risk factor surveillance system. Joint Bone Spine 2003, 70:496-502.
72. Krishnan E., Sokka T., Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res Ther 2003, 5:R158-R162.
73. Criswell L.A., Merlino L.A., Cerhan J.R., Mikuls T.R., Mudano A.S., Burma M., et al. Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am J Med 2002, 112:465-471.
74. Costenbader K.H., Feskanich D., Mandl L.A., Karlson E.W. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006, 119:e1-e9. 503.
75. Stolt P., Bengtsson C., Nordmark B., Lindblad S., Lundberg I., Klareskog L., et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003, 62:835-841.
76. Voigt L.F., Koepsell T.D., Nelson J.L., Dugowson C.E., Daling J.R. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 1994, 5:525-532.
77. Reckner Olsson A., Skogh T., Wingren G. Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis. Ann Rheum Dis 2001, 60:934-939.
78. Olsson A.R., Skogh T., Wingren G. Aetiological factors of importance for the development of rheumatoid arthritis. Scand J Rheumatol 2004, 33:300-306.
79. Sugiyama D., Nishimura K., Tamaki K., Tsuji G., Nakazawa T., Morinobu A., et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2010, 69:70-81.
80. Kallberg H., Ding B., Padyukov L., Bengtsson C., Ronnelid J., Klareskog L., et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2011, 70:508-511.
81. Saag K.G., Cerhan J.R., Kolluri S., Ohashi K., Hunninghake G.W., Schwartz D.A. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997, 56:463-469.
82. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000, 27:630-637.
83. Manfredsdottir V.F., Vikingsdottir T., Jonsson T., Geirsson A.J., Kjartansson O., Heimisdottir M., et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:734-740.
84. Papadopoulos N.G., Alamanos Y., Voulgari P.V., Epagelis E.K., Tsifetaki N., Drosos A.A. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients?. Clin Exp Rheumatol 2005, 23:861-866.
85. Westhoff G., Rau R., Zink A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 2008, 47:849-854.
86. Soderlin M., Petersson I., Bergman S., Svensson B. Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA. Scand J Rheumatol 2011, 40:249-255.
87. Mikuls T.R., Hughes L.B., Westfall A.O., Holers V.M., Parrish L., Van der Heijde D., et al. Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 2008, 67:1529-1534.
88. Lee H.S., Irigoyen P., Kern M., Lee A., Batliwalla F., Khalili H., et al. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum 2007, 56:1745-1753.
89. Masdottir B., Jonsson T., Manfredsdottir V., Vikingsson A., Brekkan A., Valdimarsson H. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 2000, 39:1202-1205.
90. Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38-46.
91. Lee D.M., Phillips R., Hagan E.M., Chibnik L.B., Costenbader K.H., Schur P.H. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 2009, 68:201-208.
92. Michou L., Teixeira V.H., Pierlot C., Lasbleiz S., Bardin T., Dieude P., et al. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 2008, 67:466-470.
93. Linn-Rasker S.P., Van der Helm-Van Mil A.H., Van Gaalen F.A., Kloppenburg M., De Vries R.R., le Cessie S., et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2006, 65:366-371.
94. Pedersen M., Jacobsen S., Garred P., Madsen H.O., Klarlund M., Svejgaard A., et al. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum 2007, 56:1446-1453.
95. Van der Helm-Van Mil A.H., Verpoort K.N., le Cessie S., Huizinga T.W., De Vries R.R., Toes R.E. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum 2007, 56:425-432.
96. Makrygiannakis D., Hermansson M., Ulfgren A.K., Nicholas A.P., Zendman A.J., Eklund A., et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008, 67:1488-1492.
97. Baeten D., Peene I., Union A., Meheus L., Sebbag M., Serre G., et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 2001, 44:2255-2262.
98. Klareskog L., Ronnelid J., Lundberg K., Padyukov L., Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008, 26:651-675.
99. Rantapaa-Dahlqvist S., de Jong B.A., Berglin E., Hallmans G., Wadell G., Stenlund H., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749.
100. Nielen M.M., Van Schaardenburg D., Reesink H.W., Van de Stadt R.J., Van der Horst-Bruinsma I.E., De Koning M.H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
101. Ruiz-Esquide V, Gómara MJ, Peinado VI, Gómez-Puerta JA, Barberá JA, Cañete JD, et al.,Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol. 2012. doi:10.1007/s10067-012-1971-y.
102. Wood A.M., De Pablo P., Buckley C.D., Ahmad A., Stockley R.A. Smoke exposure as a determinant of autoantibody titre in alpha-antitrypsin deficiency and COPD. Eur Respir J 2011, 37:32-38.
103. Harrison B.J., Silman A.J., Wiles N.J., Scott D.G., Symmons D.P. The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum 2001, 44:323-330.
104. Finckh A., Dehler S., Costenbader K.H., Gabay C. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2007, 66:1066-1071.
105. Ruiz-Esquide V., Gomez-Puerta J.A., Canete J.D., Graell E., Vazquez I., Ercilla M.G., et al. Effects of Smoking on Disease Activity and Radiographic Progression in Early Rheumatoid Arthritis. J Rheumatol 2011, 38:2536-2539.
106. Salliot C., Dawidowicz K., Lukas C., Guedj M., Paccard C., Benessiano J., et al. PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort. Rheumatology (Oxford) 2011, 50:1802-1808.
107. Rojas-Serrano J., Perez L.L., Garcia C.G., Moctezuma F., Alvarez-Hernandez E., Vazquez-Mellado J., et al. Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study. Clin Rheumatol 2011, 30:1589-1593.
108. Turesson C., O'Fallon W.M., Crowson C.S., Gabriel S.E., Matteson E.L. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003, 62:722-727.
109. Saag K.G., Kolluri S., Koehnke R.K., Georgou T.A., Rachow J.W., Hunninghake G.W., et al. Rheumatoid arthritis lung disease Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996, 39:1711-1719.
110. Lee H.K., Kim D.S., Yoo B., Seo J.B., Rho J.Y., Colby T.V., et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005, 127:2019-2027.
111. Wessels J.A., Van der Kooij S.M., le Cessie S., Kievit W., Barerra P., Allaart C.F., et al. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum 2007, 56:1765-1775.
112. Saevarsdottir S., Wedren S., Seddighzadeh M., Bengtsson C., Wesley A., Lindblad S., et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts. Arthritis Rheum 2011, 63:26-36.
113. Hyrich K.L., Watson K.D., Silman A.J., Symmons D.P. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 2006, 45:1558-1565.
114. Mattey D.L., Brownfield A., Dawes P.T. Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis. J Rheumatol 2009, 36:1180-1187.
115. Abhishek A., Butt S., Gadsby K., Zhang W., Deighton C.M. Anti-TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smokers. J Clin Rheumatol 2010, 16:15-18.
116. Van den Broek M., Klarenbeek N.B., Dirven L., Van Schaardenburg D., Hulsmans H.M., Kerstens P.J., et al. Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Ann Rheum Dis 2011, 70:1389-1394.
117. Stamp L.K., O'Donnell J.L., Chapman P.T., Zhang M., Frampton C., James J., et al. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. Arthritis Rheum 2009, 60:2248-2256.
118. Glossop J.R., Dawes P.T., Mattey D.L. Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:1223-1229.
119. Mattey D.L., Hutchinson D., Dawes P.T., Nixon N.B., Clarke S., Fisher J., et al. Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 2002, 46:640-646.
120. Forslind K., Ahlmen M., Eberhardt K., Hafstrom I., Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004, 63:1090-1095.
121. Chung H.Y., Machado P., Van der Heijde D., D'Agostino M.A., Dougados M. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis 2011.
122. Poddubnyy D., Haibel H., Listing J., Marker-Hermann E., Zeidler H., Braun J., et al. Baseline radiographic damage, elevated acute phase reactants and cigarette smoking status predict radiographic progression in the spine in early axial spondyloarthritis. Arthritis Rheum 2011.
123. Eder L., Law T., Chandran V., Shanmugarajah S., Shen H., Rosen C.F., et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken) 2011, 63:1091-1097.